Acutus medical reports preliminary, unaudited fourth quarter and full year 2020 results

Carlsbad, calif., jan. 13, 2021 (globe newswire) -- acutus medical, inc. (“acutus”) (nasdaq: afib), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported preliminary unaudited revenue results for the quarter and full year ended december 31, 2020.
AFIB Ratings Summary
AFIB Quant Ranking